10-79938341-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003019.5(SFTPD):​c.752-113C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.628 in 882,676 control chromosomes in the GnomAD database, including 176,824 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35667 hom., cov: 31)
Exomes 𝑓: 0.62 ( 141157 hom. )

Consequence

SFTPD
NM_003019.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.85

Publications

3 publications found
Variant links:
Genes affected
SFTPD (HGNC:10803): (surfactant protein D) The protein encoded by this gene is part of the innate immune response, protecting the lungs against inhaled microorganisms and chemicals. The encoded protein may also be involved in surfactant metabolism. [provided by RefSeq, Jul 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 10-79938341-G-A is Benign according to our data. Variant chr10-79938341-G-A is described in ClinVar as [Benign]. Clinvar id is 1239741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.818 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPDNM_003019.5 linkc.752-113C>T intron_variant Intron 7 of 7 ENST00000372292.8 NP_003010.4 P35247
SFTPDXM_011540087.2 linkc.752-113C>T intron_variant Intron 7 of 7 XP_011538389.1 P35247
SFTPDXM_011540088.3 linkc.635-113C>T intron_variant Intron 6 of 6 XP_011538390.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPDENST00000372292.8 linkc.752-113C>T intron_variant Intron 7 of 7 1 NM_003019.5 ENSP00000361366.3 P35247

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102766
AN:
151826
Hom.:
35609
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.825
Gnomad AMI
AF:
0.623
Gnomad AMR
AF:
0.647
Gnomad ASJ
AF:
0.639
Gnomad EAS
AF:
0.779
Gnomad SAS
AF:
0.734
Gnomad FIN
AF:
0.592
Gnomad MID
AF:
0.697
Gnomad NFE
AF:
0.598
Gnomad OTH
AF:
0.666
GnomAD4 exome
AF:
0.618
AC:
451638
AN:
730732
Hom.:
141157
AF XY:
0.621
AC XY:
232819
AN XY:
374790
show subpopulations
African (AFR)
AF:
0.827
AC:
14702
AN:
17788
American (AMR)
AF:
0.611
AC:
15213
AN:
24908
Ashkenazi Jewish (ASJ)
AF:
0.635
AC:
10113
AN:
15914
East Asian (EAS)
AF:
0.740
AC:
25814
AN:
34864
South Asian (SAS)
AF:
0.718
AC:
40035
AN:
55764
European-Finnish (FIN)
AF:
0.606
AC:
20690
AN:
34168
Middle Eastern (MID)
AF:
0.657
AC:
2091
AN:
3184
European-Non Finnish (NFE)
AF:
0.590
AC:
300260
AN:
508578
Other (OTH)
AF:
0.639
AC:
22720
AN:
35564
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
8598
17195
25793
34390
42988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5794
11588
17382
23176
28970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.677
AC:
102889
AN:
151944
Hom.:
35667
Cov.:
31
AF XY:
0.679
AC XY:
50412
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.825
AC:
34204
AN:
41446
American (AMR)
AF:
0.648
AC:
9910
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
2217
AN:
3472
East Asian (EAS)
AF:
0.779
AC:
4007
AN:
5142
South Asian (SAS)
AF:
0.734
AC:
3534
AN:
4812
European-Finnish (FIN)
AF:
0.592
AC:
6226
AN:
10524
Middle Eastern (MID)
AF:
0.692
AC:
202
AN:
292
European-Non Finnish (NFE)
AF:
0.598
AC:
40607
AN:
67948
Other (OTH)
AF:
0.671
AC:
1415
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1620
3241
4861
6482
8102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.652
Hom.:
4376
Bravo
AF:
0.685
Asia WGS
AF:
0.772
AC:
2685
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.18
DANN
Benign
0.52
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2819098; hg19: chr10-81698097; COSMIC: COSV64852998; COSMIC: COSV64852998; API